课题基金 / 基金详情

Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan

Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan
新型分泌酶 J18 对健康和寿命的影响
批准号:
10468187
负责人:
Shangang Zhao
金额:
$11.32万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-15 至 2022-10-31

项目摘要

项目成果

Shangang Zhao的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 本建议书概述了一个完整的培训和研究计划,供赵善刚博士完成 在Philipp E.博士的指导下进行进一步的学术培训。谢勒和过渡到 专门从事新陈代谢和老年科学领域的独立调查员。总体目标 这项研究的目的是探索一种新的分泌蛋白质,称为“J18”, 健康和寿命。在小鼠和人的唾液腺中高度表达, 的糖基化J18被分泌到唾液中,唾液是一种易于获得的生物材料,用于多种生物医学用途。 测定。J18显示出独特的调节模式:其水平在代谢健康状态下增加, 如禁食和热量限制,而在代谢不良的情况下,如 衰老和肥胖。从我们的J18转基因和敲除小鼠模型中积累的证据, 我们发现J18是一种新的脂质水解酶,靶向于一种独特的脂质类,以介导其有效的 促进代谢健康的效果。此外,初步数据表明,增加J18水平, 我们的肝脏J18转基因小鼠似乎延长了寿命,并且在我们的J18全球KO中J18缺乏 小鼠的平均寿命缩短。J18生理学的基本原理得到了显著的保存 从老鼠到人类。这些发现帮助我们定义了以前的生理作用, 代谢方面未知蛋白J18。我们将利用我们新产生的组织特异性 转基因和KO小鼠模型,以操纵全身J18水平,沿着J18靶向-独特 脂质类,并将解决:1)唾液来源的J18可能是一个潜在的和新的衰老生物标志物, 可以很容易地预测个人的预期寿命; 2)J18对健康和寿命的影响。 结合起来,这些研究将为J18的生理作用提供重要的新见解, 健康和寿命。J18作为一种潜在的衰老生物标志物的拟议作用满足了迫切需要。 我们需要一种易于分析、有效和有效的衰老生物标志物, 老年科学研究在德克萨斯大学西南医学中心的赞助下, 沿着以前的经验,在研究脂联素在healthspan的影响,我将 由国际公认的新陈代谢领导者指导,并由顶级衰老专家提供建议, 这将极大地促进我的研究生涯向独立调查员的转变 位置
英文摘要
Project Summary/Abstract This proposal outlines an integrated training and research plan for Dr. Shangang Zhao to complete further academic training under the mentorship of Dr. Philipp E. Scherer and transition to an independent investigator specializing in the field of metabolism and geroscience. The overall objective of the research proposal is to explore the impact of a novel secreting protein, referred to as “J18” in healthspan and lifespan. Highly expressed in salivary glands both in mouse and human, large amounts of glycosylated J18 are secreted into saliva, an easily accessible biomaterial for multiple biomedical assays. J18 displays a unique pattern of regulation: Its level is increased in metabolically healthy states, such as fasting and calorie restriction, while decreased in metabolically adverse conditions, such as aging and obesity. With evidence accumulated from our J18 transgenic and knockout mouse models, we found that J18 is a novel lipid hydrolase, targeting on a unique lipid class to mediate its potent effects in promoting metabolic health. In addition, preliminary data suggest that increasing J18 level in our liver J18 transgenic mouse seems to prolong life span and deficiency of J18 in our J18 global KO mice reduces median life span. The basic principle of J18 physiology has been conserved remarkably well from mouse to human. These findings helped us define the physiological role of a previously unknown protein J18 in metabolic aspect. We will take advantage of our newly generated tissue specific transgenic and KO mouse models to manipulate systemic J18 level, along with the J18 targeted- unique lipid class, and will address: 1) saliva-derived J18 may be a potential and novel aging biomarker to allow easy prediction of an individual's life expectancy; 2) the impact of J18 in healthspan and lifespan. Combined, these studies will provide significant new insights into the physiological effects of J18 in healthspan and lifespan. The proposed role of J18 as a potential aging biomarker meets the urgent need for an easily assayable, validated and effective aging biomarker, and will greatly advance research in geroscience. Under the auspices of the University of Texas Southwestern Medical Center, along with the previous experience gained in studying the impact of adiponectin in healthspan, I will be mentored by internationally recognized leaders in the metabolism, and advised by the top aging experts, which will greatly facilitate the transition of my research career toward an independent investigator position.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2478/jtim-2022-0039
发表时间: 2022-09
期刊: JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE
影响因子: 4.9
作者: [Li, Chao, Sun, Xue-Nan, Zhao, Shangang, Scherer, Philipp E.]
通讯作者: Scherer, Philipp E.
Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan
Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan
  • 批准号:
    10301299
  • 项目类别:
  • 资助金额:
    $11.32万
  • 财政年份:
    2021
  • 负责人:
    Shangang Zhao
  • 依托单位:
海外基金